Peripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development ...Middle East

AACHEN, Germany, Dec. 16, 2020 /PRNewswire/ -- Grünenthal announced today that the first participants have been enrolled in a Phase I trial of a peripherally restricted Nociceptin/orphanin peptide receptor (NOP) agonist, an oral investigational medicine with a unique mechanism of action...

Hence then, the article about peripheral nop agonist addressing chronic peripheral neuropathic pain enters clinical development was published today ( Wednesday 16/12/2020 - 01:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Peripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development )

Also on site :

• Legally Blonde Prequel Series Elle Is 'Officially Canon' With The Movie, EPs Confirm — Here's How They Made Sure 'Everything Tracked'
• Pretty in Pink: ‘Elle’ Star Lexi Minetree Wears Reese Witherspoon’s 2014 Met Gala Look to London Premiere of ‘Legally Blonde’ Prequel
• America’s Forgotten Soldiers: The Black Patriots Project